Literature DB >> 33594871

Low diaphragm muscle mass predicts adverse outcome in patients hospitalized for COVID-19 pneumonia: an exploratory pilot study.

Francesco Corradi1,2, Alessandro Isirdi3,4, Paolo Malacarne5, Gregorio Santori6, Greta Barbieri7, Chiara Romei5, Tiziana Bove8, Luigi Vetrugno8, Marco Falcone7, Pietro Bertini5, Fabio Guarracino5, Giovanni Landoni9,10, Francesco Forfori3,4.   

Abstract

BACKGROUND: The aim of this study was to evaluate whether measurement of diaphragm thickness (DT) by ultrasonography may be a clinically useful noninvasive method for identifying patients at risk of adverse outcomes defined as need of invasive mechanical ventilation or death.
METHODS: We prospectively enrolled 77 patients with laboratory-confirmed COVID-19 infection admitted to our intermediate care unit in Pisa between March 5 and March 30, 2020, with follow-up until hospital discharge or death. Logistic regression was used identify variables potentially associated with adverse outcomes and those P<0.10 were entered into a multivariate logistic regression model. Cumulative probability for lack of adverse outcomes in patients with or without low baseline diaphragm muscle mass was calculated with the Kaplan-Meier product-limit estimator.
RESULTS: The main findings of this study are that: 1) patients who developed adverse outcomes had thinner diaphragm than those who did not (2.0 vs. 2.2 mm, P=0.001); and 2) DT and lymphocyte count were independent significant predictors of adverse outcomes, with end-expiratory DT being the strongest (ß=-708; OR=0.492; P=0.018).
CONCLUSIONS: Diaphragmatic ultrasound may be a valid tool to evaluate the risk of respiratory failure. Evaluating the need of mechanical ventilation treatment should be based not only on PaO<inf>2</inf>/FiO<inf>2</inf>, but on a more comprehensive assessment including DT because if the lungs become less compliant a thinner diaphragm, albeit free of intrinsic abnormality, may become exhausted, thus contributing to severe respiratory failure.

Entities:  

Year:  2021        PMID: 33594871     DOI: 10.23736/S0375-9393.21.15129-6

Source DB:  PubMed          Journal:  Minerva Anestesiol        ISSN: 0375-9393            Impact factor:   3.051


  3 in total

Review 1.  Complications of Critical COVID-19: Diagnostic and Therapeutic Considerations for the Mechanically Ventilated Patient.

Authors:  David M Maslove; Stephanie Sibley; J Gordon Boyd; Ewan C Goligher; Laveena Munshi; Isaac I Bogoch; Bram Rochwerg
Journal:  Chest       Date:  2021-10-13       Impact factor: 10.262

2.  Diaphragm ultrasound to stratify COVID-19 patients in the emergency department?

Authors:  Abdallah Fayssoil; Sebastien Beaune; Benjamin Davido; Nicolas Mansencal
Journal:  J Clin Ultrasound       Date:  2021-10-11       Impact factor: 0.869

3.  Diaphragm ultrasound evaluation during weaning from mechanical ventilation in COVID-19 patients: a pragmatic, cross-section, multicenter study.

Authors:  Luigi Vetrugno; Daniele Orso; Francesco Corradi; Gianluca Zani; Savino Spadaro; Francesco Meroi; Natascia D'Andrea; Tiziana Bove; Gianmaria Cammarota; Edoardo De Robertis; Samuele Ferrari; Marcello Guarnieri; Margherita Ajuti; Maurizio Fusari; Domenico Luca Grieco; Cristian Deana; Enrico Boero; Federico Franchi; Sabino Scolletta; Salvatore Maurizio Maggiore; Francesco Forfori
Journal:  Respir Res       Date:  2022-08-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.